| RS2146622848 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS2146626308 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2146634231 |
ADSL
|
Health Risk |
Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS2146638782 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2146643195 |
TMEM94
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2146646096 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2146647668 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146649701 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146652075 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2146652117 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2146653193 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2146653379 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2146654092 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 16 |
| RS2146654353 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2146655550 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2146656223 |
CHKB
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2146656234 |
CHKB
|
Health Risk |
Pathogenic |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS2146656742 |
CHKB
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, Muscular dystrophy |
| RS2146658002 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146658733 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS2146659025 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146661259 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2146664115 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2146664989 |
VPS16
|
Health Risk |
Pathogenic |
Dystonia 30, Dystonia 30 |
| RS2146666663 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146667709 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS2146669693 |
VPS16
|
Health Risk |
Pathogenic |
Dystonia 30, Dystonia 30 |
| RS2146671573 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2146673211 |
VPS16
|
Health Risk |
Likely pathogenic |
Dystonia 30, Dystonia 30 |
| RS2146675486 |
ADGRG2
|
Health Risk |
Likely pathogenic |
Vas deferens, congenital bilateral aplasia of |
| RS2146678594 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146684218 |
GPR143
|
Health Risk |
Likely pathogenic |
— |
| RS2146684328 |
GPR143
|
Health Risk |
Pathogenic |
GPR143-related disorder, GPR143-related disorder |
| RS2146684649 |
PIGU
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 21, Glycosylphosphatidylinositol biosynthesis defect 21 |
| RS2146685691 |
GPR143
|
Health Risk |
Likely pathogenic |
— |
| RS2146685694 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146685874 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146687459 |
GPR143
|
Health Risk |
Likely pathogenic |
Ocular albinism, type I |
| RS2146687477 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146689449 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146689530 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146689576 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146691632 |
GPR143
|
Health Risk |
Likely pathogenic |
Ocular albinism, type I |
| RS2146691974 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2146699322 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2146699547 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146699615 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146699662 |
GPR143
|
Health Risk |
Likely pathogenic |
— |
| RS2146699664 |
GPR143
|
Health Risk |
Pathogenic |
Ocular albinism, type I |
| RS2146700764 |
GPR143
|
Health Risk |
Pathogenic |
Ocular albinism, type I |
| RS2146700794 |
GPR143
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2146700981 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146701042 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146703685 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146705592 |
GPR143
|
Health Risk |
Likely pathogenic |
— |
| RS2146705597 |
GPR143
|
Health Risk |
Pathogenic |
Nystagmus 6, congenital |
| RS2146705633 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146705785 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146705899 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146705998 |
GPR143
|
Health Risk |
Pathogenic |
Ocular albinism, type I |
| RS2146706023 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146706095 |
GPR143
|
Health Risk |
Pathogenic |
— |
| RS2146707223 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2146715075 |
ALAS2
|
Health Risk |
Likely pathogenic |
X-linked sideroblastic anemia 1, X-linked sideroblastic anemia 1 |
| RS2146716548 |
DNAH17
|
Health Risk |
Pathogenic |
Spermatogenic failure 39, Spermatogenic failure 39 |
| RS2146716603 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146716641 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146716979 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146716994 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146717660 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146717703 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Neurodevelopmental disorder |
| RS2146717905 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146717919 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146718041 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146718906 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146722676 |
ALAS2
|
Health Risk |
Likely pathogenic |
— |
| RS2146722839 |
ALAS2
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked sideroblastic anemia 1, X-linked sideroblastic anemia 1 |
| RS2146723107 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146723372 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146725299 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146725874 |
ARSA
|
Health Risk |
Likely pathogenic |
— |
| RS2146726223 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146726825 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146727518 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146728318 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2146731397 |
ZNFX1
|
Health Risk |
Pathogenic |
Immunodeficiency 91 and hyperinflammation, Immunodeficiency 91 and hyperinflammation |
| RS2146732210 |
ZNFX1
|
Health Risk |
Pathogenic |
— |
| RS2146732308 |
ZNFX1
|
Health Risk |
Pathogenic |
Immunodeficiency 91 and hyperinflammation, Immunodeficiency 91 and hyperinflammation |
| RS2146732713 |
WNT7B
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS2146733599 |
NLGN4X
|
Health Risk |
Pathogenic |
— |
| RS2146741441 |
ZNFX1
|
Health Risk |
Pathogenic |
Immunodeficiency 91 and hyperinflammation, Immunodeficiency 91 and hyperinflammation |
| RS2146742427 |
ZNFX1
|
Health Risk |
Pathogenic |
Immunodeficiency 91 and hyperinflammation, Immunodeficiency 91 and hyperinflammation |
| RS2146757484 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Melanoma |
| RS2146758722 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2146765756 |
TRAPPC2
|
Health Risk |
Likely pathogenic |
— |
| RS2146767502 |
TLK2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2146772777 |
SHANK3
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2146772952 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Inborn genetic diseases |
| RS2146773091 |
TRAPPC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepiphyseal dysplasia tarda, X-linked |
| RS2146775051 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |